I. Cumin

EGFR Expression Is Unreliable to Decide for Cetuximab Treatment in Patients with Metastatic Colorectal Cancer: Results from “ERBITUX-OUEST”

J. Douillard, N. Padilla, J. Raoul, 2016 .

Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC study.

J. Mazières, G. Quéré, A. Vergnenègre, 2011, Lung cancer.

Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients

F. Joly, J. Malhaire, E. Voog, 2020, International journal of cancer.

Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.

J. Douillard, J. Metges, Z. Alavi, 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial

P. Ingrand, P. Colombat, P. Solal-Céligny, 2014, American journal of hematology.

Management of Esophageal Carcinoma Associated with Cirrhosis: A Retrospective Case-Control Analysis

F. Trivin, J. Raoul, O. Audrain, 2009, Journal of oncology.

Rothmund-Thomson syndrome and osteosarcoma.

H. Avet-Loiseau, J. Harousseau, I. Cumin, 1996, Medical and pediatric oncology.

Metastatic melanoma: results of ‘classical' second-line treatment with cytotoxic chemotherapies

M. Pracht, H. Mesbah, T. Lesimple, 2014, The Journal of dermatological treatment.

[Efficacy of the combination of mitomycin, ifosfamide and cisplatin with irradiation for the treatment of cerebral metastasis in non small cell lung carcinoma].

J. Dutin, H. Lacroix, G. Dabouis, 1995, Bulletin du cancer.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

P. Couzigou, M. Ducreux, C. Borel, 2018, European journal of cancer.

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics

J. Douillard, P. Langlet, E. Jobard, 2014, Oncologie.